(Q35572432)

8 August 2017

1 reference

title

Breast cancer prevention trials using retinoids (English)

1 reference

8 August 2017

Aliana Guerrieri Gonzaga

0 references

author name string

Andrea Decensi

1

1 reference

8 August 2017

Davide Serrano

2

1 reference

8 August 2017

Bernardo Bonanni

3

1 reference

8 August 2017

Massimiliano Cazzaniga

4

1 reference

8 August 2017

Aliana Guerrieri-Gonzaga

5

1 reference

8 August 2017

1 January 2003

1 reference

Journal of Mammary Gland Biology and Neoplasia

8 August 2017

1 reference

8 August 2017

8

1 reference

8 August 2017

19-30

1 reference

8 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1025779120649

8 August 2017

0 references

cites work

Effect of fenretinide on ovarian carcinoma occurrence

1 reference

12 December 2020

Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.

1 reference

12 December 2020

Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors

1 reference

12 December 2020

Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.

1 reference

12 December 2020

4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors

1 reference

12 December 2020

Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.

1 reference

12 December 2020

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia

1 reference

12 December 2020

Effects of fenretinide (4-HPR) on dark adaptation

1 reference

12 December 2020

Aberrant retinoid signaling and breast cancer: the view from outside the nucleus

1 reference

12 December 2020

Tolerability of the synthetic retinoid Fenretinide (HPR)

1 reference

12 December 2020

The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial

1 reference

12 December 2020

N-(4-hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells

1 reference

12 December 2020

Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China

1 reference

12 December 2020

Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats

1 reference

12 December 2020

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

1 reference

12 December 2020

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

1 reference

12 December 2020

Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells

1 reference

12 December 2020

Role of the insulin-like growth factor family in cancer development and progression

1 reference

12 December 2020

Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer

1 reference

12 December 2020

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner

1 reference

12 December 2020

A new class of retinoids with selective inhibition of AP-1 inhibits proliferation

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients

1 reference

12 December 2020

In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences

1 reference

12 December 2020

Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer

1 reference

12 December 2020

The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients

1 reference

12 December 2020

Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor

1 reference

12 December 2020

Insulin-like growth factor physiology and cancer risk

1 reference

12 December 2020

Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide

1 reference

12 December 2020

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

1 reference

12 December 2020

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

12 December 2020

Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer.

1 reference

12 December 2020

Retinoids and their receptors in cancer development and chemoprevention

1 reference

12 December 2020

Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen

1 reference

12 December 2020

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

12 December 2020

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

12 December 2020

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women

1 reference

12 December 2020

Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer

1 reference

12 December 2020

Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer

1 reference

12 December 2020

A method to assess the proportion of treatment effect explained by a surrogate endpoint

1 reference

12 December 2020

N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat

1 reference

12 December 2020

Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen

1 reference

12 December 2020

Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.

1 reference

12 December 2020

Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene

1 reference

12 December 2020

Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss

1 reference

12 December 2020

The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.

1 reference

12 December 2020

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

1 reference

12 December 2020

Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations

1 reference

12 December 2020

Retinoids and apoptosis: implications for cancer chemoprevention and therapy

1 reference

12 December 2020

Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)

1 reference

12 December 2020

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

12 December 2020

Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.

1 reference

12 December 2020

Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell Cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1).

1 reference

12 December 2020

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1 reference

12 December 2020

Effect of the synthetic retinoid fenretinide on dark adaptation and the ocular surface

1 reference

12 December 2020

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer

1 reference

12 December 2020

Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells

1 reference

12 December 2020

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

1 reference

12 December 2020

RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors

1 reference

12 December 2020

A decade of molecular biology of retinoic acid receptors

1 reference

12 December 2020

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

1 reference

12 December 2020

Can fenretinide protect women against ovarian cancer?

1 reference

12 December 2020

Cancer chemoprevention: progress and promise

1 reference

12 December 2020

Statistical validation of intermediate endpoints for chronic diseases

1 reference

12 December 2020

Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials

1 reference

12 December 2020

Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone

1 reference

12 December 2020

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Distribution of fenretinide in the mammary gland of breast cancer patients

1 reference

12 December 2020

Hepatocyte growth factor and retinoic acid exert opposite effects on synthesis of type 1 and type 2 acute phase proteins in rat hepatoma cells

1 reference

12 December 2020

Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.

1 reference

12 December 2020

Tamoxifen and fenretinide in women with metastatic breast cancer

1 reference

12 December 2020

Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients

1 reference

12 December 2020

Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye

1 reference

12 December 2020

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

12 December 2020

Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide

1 reference

12 December 2020

Contralateral breast cancer: annual incidence and risk parameters.

1 reference

12 December 2020

Clinical development plan: N-(4-hydroxyphenyl)retinamide

1 reference

12 December 2020

Serum insulin-like growth factor-I and breast cancer.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1025779120649

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference